← Evidence map

ArticleFrontiers in oncology2021

Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection.

Yuanyuan Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

1 paper cites it

2021
2022
this papercites it
Full record →Abstract, authors, funding and every citing paper · PMID 34109131